Analyzing GoodRx (NASDAQ:GDRX) & Tintri (OTCMKTS:TNTRQ)

GoodRx (NASDAQ:GDRX) and Tintri (OTCMKTS:TNTRQ) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, dividends, earnings, profitability, analyst recommendations, institutional ownership and valuation.

Valuation and Earnings

This table compares GoodRx and Tintri’s gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
GoodRx $550.70 million 33.31 -$293.62 million ($0.96) -48.29
Tintri N/A N/A N/A N/A N/A

Tintri has lower revenue, but higher earnings than GoodRx.


This table compares GoodRx and Tintri’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
GoodRx -50.01% -39.62% -19.70%
Tintri N/A N/A N/A

Insider and Institutional Ownership

35.9% of GoodRx shares are held by institutional investors. 1.4% of GoodRx shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Analyst Recommendations

This is a breakdown of current ratings and recommmendations for GoodRx and Tintri, as provided by

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
GoodRx 1 5 9 0 2.53
Tintri 0 0 0 0 N/A

GoodRx presently has a consensus target price of $47.93, indicating a potential upside of 3.39%. Given GoodRx’s higher probable upside, equities research analysts plainly believe GoodRx is more favorable than Tintri.


GoodRx beats Tintri on 5 of the 8 factors compared between the two stocks.

GoodRx Company Profile

GoodRx Holdings, Inc., through its subsidiaries, provides information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices through GoodRx codes that are used to save money on prescriptions across the United States. It also offers other healthcare products and services, including telehealth services. The company serves pharmacy benefit managers that manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies. GoodRx Holdings, Inc. was incorporated in 2015 and is based in Santa Monica, California.

Tintri Company Profile

Tintri, Inc. engages in the provision of cloud platform that offers public cloud capabilities inside its own data centers and can also connect to public cloud services. It offers products and services such as all-flash array, hybrid-flash array, management, analytics, scale, and software. The company was founded by Mark G. Gritter and Kieran J. Harty in June 2008 and is headquartered in Mountain View, CA.

Receive News & Ratings for GoodRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GoodRx and related companies with's FREE daily email newsletter.